MALPEZZI, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 2.150
NA - Nord America 1.572
EU - Europa 1.441
SA - Sud America 243
AF - Africa 57
OC - Oceania 8
Totale 5.471
Nazione #
US - Stati Uniti d'America 1.517
CN - Cina 745
SG - Singapore 596
IT - Italia 540
VN - Vietnam 193
BR - Brasile 192
HK - Hong Kong 184
DE - Germania 177
KR - Corea 132
GB - Regno Unito 130
SE - Svezia 120
FR - Francia 82
RU - Federazione Russa 79
FI - Finlandia 58
ID - Indonesia 48
IN - India 46
ES - Italia 44
NL - Olanda 41
BD - Bangladesh 35
JP - Giappone 34
CA - Canada 30
BE - Belgio 27
IQ - Iraq 25
CH - Svizzera 22
LT - Lituania 22
PL - Polonia 18
ZA - Sudafrica 15
AR - Argentina 14
IR - Iran 14
AT - Austria 13
MX - Messico 13
TR - Turchia 13
CL - Cile 11
IE - Irlanda 11
CZ - Repubblica Ceca 10
MY - Malesia 10
SA - Arabia Saudita 10
TW - Taiwan 10
UZ - Uzbekistan 10
EC - Ecuador 9
MA - Marocco 9
PH - Filippine 8
PK - Pakistan 8
PY - Paraguay 7
TN - Tunisia 7
UA - Ucraina 7
AU - Australia 6
DZ - Algeria 6
VE - Venezuela 6
ET - Etiopia 5
KE - Kenya 5
BY - Bielorussia 4
EG - Egitto 4
GR - Grecia 4
HU - Ungheria 4
KZ - Kazakistan 4
LI - Liechtenstein 4
NO - Norvegia 4
PT - Portogallo 4
RS - Serbia 4
AZ - Azerbaigian 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
IL - Israele 3
JO - Giordania 3
MO - Macao, regione amministrativa speciale della Cina 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BH - Bahrain 2
CR - Costa Rica 2
GH - Ghana 2
JM - Giamaica 2
LB - Libano 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SN - Senegal 2
TH - Thailandia 2
BO - Bolivia 1
CO - Colombia 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
UY - Uruguay 1
Totale 5.471
Città #
Hefei 379
Singapore 374
Santa Clara 332
San Jose 197
Ashburn 177
Hong Kong 176
Seoul 119
Council Bluffs 92
Modena 80
Ho Chi Minh City 71
Frankfurt am Main 67
London 66
Beijing 65
New York 47
Los Angeles 46
Bologna 43
The Dalles 39
Jakarta 38
Munich 38
Hanoi 37
Helsinki 37
Milan 37
Nyköping 33
Boardman 30
Chandler 26
Lauterbourg 26
Reggio Emilia 24
Parma 23
Kent 21
Orem 21
Dallas 20
Moscow 20
Buffalo 19
Shanghai 19
Amsterdam 18
Padova 17
Warsaw 16
Leuven 15
São Paulo 15
Hangzhou 14
Barcelona 13
Decatur 13
Lappeenranta 13
Madrid 13
Chennai 12
Chicago 12
Rome 12
Tokyo 11
Zurich 11
Da Nang 10
Manchester 10
Tehran 10
Atlanta 9
Boston 9
Brussels 9
Santiago 9
Tashkent 9
Brooklyn 8
Denver 8
Dublin 8
Formigine 8
Nuremberg 8
Phoenix 8
Stockholm 8
Vienna 8
Washington 8
Argenta 7
Biên Hòa 7
Charlotte 7
Kuala Lumpur 7
Mexico City 7
Montreal 7
Ottawa 7
Poplar 7
Belo Horizonte 6
Brno 6
East Wenatchee 6
Guangzhou 6
Johannesburg 6
Leipzig 6
Osnabrück 6
Princeton 6
Rossdorf 6
Turku 6
Addis Ababa 5
Ankara 5
Cebu City 5
Ferrara 5
Hillsboro 5
Juiz de Fora 5
Marseille 5
Paris 5
Piacenza 5
Portsmouth 5
Raleigh 5
Rio de Janeiro 5
Riyadh 5
San Diego 5
Seattle 5
Toronto 5
Totale 3.387
Nome #
Designing selective Cys-ligands to unpair the binding of the Human Transcription Enhancer Associated Domain 4 (hTEAD-4) with its modulators to halt cancer cell growth 298
Exploiting Forster Resonance Energy Transfer (FRET) in the characterization of YAP:TEAD complex disruption 267
Development of a novel class of YAP:TEAD interface-3 molecular disruptors to treat colorectal carcinoma 240
A toolbox of biophysical and analytical assays helps to confirm the activity of novel hTS dimer disrupters (Ddis) with anticancer properties 238
design, synthesis and biological evaluation of novel YAP:TEAD complex disruptors for thetreatment of colorectal cancer 237
Applying optical tweezers technology to reveal Thymidylate Synthase interactions with its consensus mRNA 226
Current Treatments to Control African Trypanosomiasis and One Health Perspective 208
Lead optimization of human thymidylate synthase dimer disrupters: from computational studies to evaluation of their biological profiles 207
Lead-optimization process and characterization of the dissociative effect applied to new dimer disrupters of human Thymidylate Synthase 198
Exploring thymidylate synthase mRNA binding site 1 and human TS protein interaction with optical tweezers and bicistronic expression assay 197
UHPLC-MS/MS screening of the hTEAD surface for the identification of novel allosteric inhibitors with anticancer activity 184
Exploiting the Optical Tweezer technology to reveal thymidylate synthase interactions with its consensus mRNA 183
Advancing sustainable drug development: comparative preclinical study of H80 and Miltefosine using imaging and proteomics 179
EXPLOITING THE OPTICAL TWEEZER, A SINGLE MOLECULE TECHNOLOGY, TO REVEAL THYMIDYLATE SYNTHASE INTERACTIONS WITH ITS CONSENSUS mRNA 178
Intersite Communication in Dimeric Enzymes Highlighted by Structural and Thermodynamic Analysis of Didansyltyrosine Binding to Thymidylate Synthases 174
Insights into host-target interaction from the proteome modulation analysis through untargeted LC-MS/MS Proteomics of drug resistant L infantum-THP1 infected cells 171
Leveraging proteomic, bioinformatic and ecotoxicology models to select new targets overcoming L. Infantum drug resistent 167
LC-MS/MS proteomics for the rapid and selective screening of drug resistances in Leishmania infantum clinical isolates 166
Deciphering Host–Parasite Interplay in Leishmania Infection through a One Health View of Proteomics Studies on Drug Resistance 165
Investigating the mechanism of action of the antiparasitic agent H80 through imaging techniques 163
Optical tweezers to investigate at the single-molecule level the interaction of thymidylate synthase with its consensus mRNA 160
Drug discovery of pyrazolo-piperidinone inhibitors targeting YAP:TEAD interaction and development of a fluorescence anisotropy assay for high-throughput screening 156
Optimization of chemical-biological tools for characterizing the activity of dissociative inhibitor of human thymidylate synthase 154
One Health Approach in Drug Discovery for Leishmaniasis by Targeting Calpain cys-protease. 150
MS Proteomics And Biochemical Characterization Of Thymidylate Synthase Dimer Destabilizer E7 To Halt Colorectal Carcinoma 149
Promoting A Sustainable Medicinal Chemistry Approach With The Cost Action CA21111 - One Health Drugs Against Parasitic Vector Borne Diseases In Europe And Beyond 133
Leveraging proteomics, bioinformatics, and ecotoxicology models to select new targets overcoming L infantum drug resistance. 132
Targeting of the Cysteines Surface domain of the Transcriptional Enhancer Associate Domain (TEAD) for anticancer drug discovery 126
Preclinical investigation of H80 compared to miltefosine: imaging and proteomics for sustainable drug development 107
Development of a fluorescent anisotropy displacement assay for the optimization of YAP:TEAD molecular disrupters with anticancer activity 89
IDENTIFICATION OF PYRAZOLO-PIPERIDINONE DERIVATIVES TARGETING YAP-TEAD INTERFACE 3 AS ANTICANCER AGENTS THROUGH INTEGRATED VIRTUAL SCREENING AND MASS SPECTROMETRY PROTEOMICS 74
Meccanismi on-target di farmaci innovativi antitumorali e anti-infettivi studiati mediante approcci biochimici e biofisici 30
Totale 5.506
Categoria #
all - tutte 18.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.999


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 0 0 0 17 9 6 12 4 22 13
2022/2023272 35 23 14 18 13 20 18 35 50 1 31 14
2023/2024651 38 43 47 28 146 38 65 54 16 9 98 69
2024/20251.723 55 33 64 101 290 252 135 89 169 70 249 216
2025/20262.777 252 209 284 353 322 143 354 131 247 261 138 83
Totale 5.506